Oliver Luxxe Assets’s AstraZeneca AZN Stock Holding History

Oliver Luxxe Assets’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.52M	Buy	+45,272	New	+$8.52M	1.25%	23
2026 Q1	–	Sell	-45,734	Closed	-$8.41M	–	204
2025 Q4	$8.41M	Sell	45,734 -92	-0.2%	-$16.1K	1.28%	19
2025 Q3	$7.03M	Buy	45,826 +6,675	+17%	+$1.01M	1.11%	28
2025 Q2	$5.47M	Buy	39,151 +2,225	+6%	+$312K	0.98%	37
2025 Q1	$5.43M	Buy	+36,926	New	+$5.34M	1.01%	34
2018 Q1	–	Sell	-55,430	Closed	-$3.85M	–	91
2017 Q4	$3.85M	Sell	55,430 -2,826	-5%	-$191K	2.34%	13
2017 Q3	$3.95M	Sell	58,256 -3,004	-5%	-$190K	2.48%	10
2017 Q2	$4.18M	Buy	61,260 +1,717	+3%	+$112K	2.72%	9
2017 Q1	$3.71M	Buy	59,543 +1,831	+3%	+$107K	2.47%	9
2016 Q4	$3.15M	Buy	57,712 +32,111	+125%	+$1.82M	2.18%	17
2016 Q3	$1.68M	Buy	25,601 +1,824	+8%	+$119K	1.32%	34
2016 Q2	$1.44M	Sell	23,777 -1,081	-4%	-$62.8K	1.22%	35
2016 Q1	$1.4M	Buy	24,858 +249	+1%	+$15K	1.44%	33
2015 Q4	$1.6M	Buy	+24,609	New	+$1.61M	1.43%	23

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Oliver Luxxe Assets's AZN Position: Q2 2026 in Review

Oliver Luxxe Assets opened a new position in AstraZeneca (AZN) in Q2 2026: 45,272 shares worth $8.52M. The stake represents 1.25% of the portfolio and ranks #23 among its holdings. This is a return to the name: Oliver Luxxe Assets previously reported a position in AZN as recently as Q4 2025.

Oliver Luxxe Assets first reported a position in AZN in Q4 2015 and has held it in 14 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Oliver Luxxe Assets held 45,272 shares of AstraZeneca worth $8.52M as of Q2 2026.
AstraZeneca was a new Oliver Luxxe Assets position in Q2 2026.
AstraZeneca made up 1.25% of Oliver Luxxe Assets's portfolio in Q2 2026, its #23 holding.
Oliver Luxxe Assets first reported a position in AstraZeneca in Q4 2015 and has held it in 14 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.